AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 9,226.50
+23.50 (0.26%)
At close: Dec 5, 2025
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 230.29 billion as of December 5, 2025. Its market cap has increased by 43.98% in one year.
Market Cap
230.29B
Enterprise Value
226.64B
Revenue
20.06B
Ranking
n/a
PE Ratio
115.64
Stock Price
9,226.50
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 230.29B, an increase of 15,781.90%. That is a compound annual growth rate of 23.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 230.29B | 26.02% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | 115.54B | 76.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |